Round window application of D-methionine, sodium thiosulfate, brain-derived neurotrophic factor, and fibroblast growth factor-2 in cisplatin-induced ototoxicity

Otology and Neurotology

Volumn 25, Issue 1, 2004, Pages 33-40

  Wimmer, Christoph ^a   Mees, Klaus ^a   Stumpf, Peter ^a   Welsch, Ulrich ^a   Reichel, Oliver ^a   Suckfüll, Markus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Brain derived neurotrophic factor; Cisplatin; D methionine; Fibroblast growth factor 2; Ototoxicity; Round window membrane; Sodium thiosulfate

Indexed keywords

ANTINEOPLASTIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CISPLATIN; FIBROBLAST GROWTH FACTOR 2; METHIONINE; SODIUM THIOSULFATE; THIOSULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCHLEA; COCHLEA FENESTRA; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DRUG EFFECT; FEMALE; GUINEA PIG; NONHUMAN; OSMOTIC PUMP; OTOTOXICITY; PRIORITY JOURNAL; PROTECTION; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHEMICALLY INDUCED DISORDER; INFUSION PUMP; PERCEPTION DEAFNESS; REGRESSION ANALYSIS; SPONTANEOUS OTOACOUSTIC EMISSION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CISPLATIN; FEMALE; FIBROBLAST GROWTH FACTOR 2; GUINEA PIGS; HEARING LOSS, SENSORINEURAL; INFUSION PUMPS; METHIONINE; OTOACOUSTIC EMISSIONS, SPONTANEOUS; REGRESSION ANALYSIS; ROUND WINDOW; THIOSULFATES;

EID: 2342441227     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200401000-00007     Document Type: Article

References (34)

1. Lim D. Ultrastructural cochlear changes after acoustic hyperstimulation and ototoxicity. Ann Otol Rhinol Laryngol 1976;85:740-51.
2. Saito T, Aran J. Comparative ototoxicity of cisplatin during acute and chronic treatment. Otorhinolaryngol Relat Spec 1994;56:315-20.
3. Sone M, Schachern P, Paparella M. Loss of spiral ganglion cells as a primary manifestation of aminoglycoside ototoxicity. Hear Res 1998;115:217-23.
4. Hinojosa R, Riggs L, Strauss M, et al. Temporal bone histopathology of cisplatin ototoxicity. Am J Otol 1995;16:731-40.
5. Miettinen S, Laurell G, Andersson A, et al. Blood flow independent accumulation of cisplatin in the guinea pig cochlea. Acta Otolaryngol (Stockh) 1997;117:55-60.
6. Schweitzer V. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. Laryngoscope 1993;103:1-52.
7. Vermorken J, Kapteijn T, Hart A, et al. Ototoxicity of cis-diamminedichlorplatinum (II): influence of dose, schedule and mode of administration. Eur J Cancer Clin Oncol 1983;19:53-8.
8. Campbell K, Rybak L, Meech R, et al. D-Methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res 1996;102:90-8.
9. Campbell K, Meech R, Rybak L, et al. D-Methionine protects against cisplatin damage to the stria vascularis. Hear Res 1999;138:13-28.
10. Lockwood DS, Ding DL, Wang J, et al. D-Methionine attenuates inner hair cell loss in carboplatin-treated chinchillas. Audiol Neurootol 2000;5:263-6.
11. Ekborn A, Laurell G, Johnstrom P, et al. D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics. Hear Res 2002;165:53-61.
12. Kopke R, Gabaizadeh R, Jacono A, et al. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. Am J Otol 1999;18:559-71.
13. Ravi R, Somani S, Rybak L. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 1995;76:386-94.
14. Gabaizadeh R, Staecker H, Liu W, et al. Protection of both auditory hair cells and auditory neurons from cisplatin induced damage. Acta Otolaryngol (Stockh) 1997;117:232-8.
15. Reser D, Rho M, Dewan D, et al. L- and D- methionine provide equivalent long term protection against CDDP-induced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activity. Neurotoxicology. 1999;20:731-48.
16. Sha S, Schacht J. Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant. Hear Res 2000;142:34-40.
17. Kaltenbach J, Church M, Blakely B, et al. Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster. Otolaryngol Head Neck Surg 1997;117:493-500.
18. Saito T, Zhang Z, Manabe Y, et al. The effect of sodium thiosulfate on ototoxicity and pharmacokinetics after cisplatin treatment in guinea pig. Eur Arch Otorhinolaryngol 1997;254:281-6.
19. Madasu R, Ruckenstein M, Leake F, et al. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1997;123:978-81.
20. Neuwelt E, Brummett R, Doolittle N, et al. First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate. J Pharmacol Exp Ther 1998;286:77-84.
21. Neuwelt E, Brummett R, Remsen L, et al. In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity. Cancer Res 1996;56:706-9.
22. Church M, Kaltenbach J, Blakley B, et al. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity. Hear Res 1995;86:195-203.
23. Markman M, D'Acuisto R, Iannotti N, et al. Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate. J Cancer Res Clin Oncol 1991;117:151-5.
24. Otto W, Brown R, Gage-White L, et al. Effects of cisplatin and thiosulfate upon auditory brainstem responses of guinea pigs. Hear Res 1988;35:79-85.
25. Low W, Dazert S, Baird A, et al. Basic fibroblast growth factor (FGF-2) protects rat cochlear hair cells in organotypical culture from aminoglycoside injury. J Cell Physiol 1996;167:443-50.
26. Kingma G, Miller J, Myers M. Chronic drug infusion into the scala tympani of the guinea pig cochlea. J Neurosci Methods 1992;45:127-34.
27. Brown J, Miller J, Altschuler R, et al. Osmotic pump implant for chronic infusion of drugs into the inner ear. Hear Res 1993;70:167-72.
28. Prieskorn D, Miller J. Technical report: chronic and acute intracochlear infusion in rodents. Hear Res 2000;140:212-5.
29. Korver KD, Rybak LP, Whitworth C, et al. Round window application of D-methionine provides complete cisplatin otoprotection. Otolaryngol Head Neck Surg 2002;126:683-9.
30. Li G, Frenz DA, Brahmblatt S, et al. Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy. Neurotoxicology 2001;22:163-76.
31. Sockalingam R, Freeman S, Cherny TL, et al. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals. Am J Otol 2000;21:521-7.
32. Li G, Sha SH, Zotova E, et al. Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab Invest 2002;82:585-96.
33. Staecker H, Van de Water S. Factors controlling hair-cell regeneration/repair in the inner ear. Curr Opin Neurobiol 1998;8:480-7.
34. Dazert S, Baird A, Ryan A. Receptor-targeted delivery of an intracellular toxin to outer hair cells by fibroblast growth factor. Hear Res 1998;115:143-8.